UBS Group AG - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 64 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$68
-98.6%
65
-98.0%
0.00%
Q4 2022$4,757
-56.8%
3,258
+31.8%
0.00%
Q3 2022$11,0002,472
+27366.7%
0.00%
Q2 2022$090.0%0.00%
Q1 2022$090.0%0.00%
Q4 2021$0
-100.0%
9
-99.0%
0.00%
Q3 2021$7,000871
+9577.8%
0.00%
Q2 2021$09
-18.2%
0.00%
Q1 2021$0110.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$1,096,6370.23%
Aisling Capital Management LP 288,571$458,8280.22%
BVF INC/IL 3,614,662$5,747,3130.21%
Rubric Capital Management LP 1,487,385$2,364,9420.06%
HAMILTON LANE ADVISORS LLC 35,791$570.02%
MAI Capital Management 379,468$603,3540.01%
Laurion Capital Management LP 698,000$1,109,8200.01%
TRUST CO OF TOLEDO NA /OH/ 28,000$44,5200.01%
RP Management, LLC 3,700$5,8830.01%
Jasper Ridge Partners, L.P. 92,939$147,7730.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders